Cargando…
Stem cell therapy for insulin-dependent diabetes: Are we still on the road?
In insulin-dependent diabetes, the islet β cells do not produce enough insulin and the patients must receive exogenous insulin to control blood sugar. However, there are still many deficiencies in exogenous insulin supplementation. Therefore, the replacement of destroyed functional β cells with insu...
| Autores principales: | , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Baishideng Publishing Group Inc
2022
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9350623/ https://www.ncbi.nlm.nih.gov/pubmed/36157527 http://dx.doi.org/10.4252/wjsc.v14.i7.503 |